Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP39 inhibits cell growth aerobic glycolysis oral cancer. 1 / 1

| 1

➶

eidos

"Elevated Sad1 and UNC84 Domain Containing 2 ( SUN2 ) level inhibits cell growth and aerobic glycolysis in oral cancer through reducing the expressions of glucose transporter 1 ( GLUT1 ) and lactate dehydrogenase A ( LDHA ) Background / purpose Oral cancer is a malignant tumor accompanied by high morbidity , mortality , and poor prognosis ."

33384835

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...